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This paper describes problems that arose over the publication of a study of chlamydia screening, which was completed in 2000. The account has been agreed by the authors of the papers, the editors of the two journals involved and by the Council of the Committee on Publication Ethics (COPE). The aim of revisiting events that occurred several years ago is to describe some of the difficulties that can arise, even when all parties act in good faith, with the hope of preventing similar problems in the future and to make readers aware of the publication history of the three papers. The UK Department of Health (DH) funded a large-scale study of opportunistic screening for chlamydia. One of the two centres involved in the study was Portsmouth. It was agreed from the outset that the Portsmouth data would be published separately, because screening methodology had differed between the two centres. The Portsmouth investigators therefore felt their presentation would be a valid separate analysis, with important messages for a different audience from the paper describing the national findings. A paper 1 describing the national results from the study including data from Portsmouth was submitted to the BMJ in April 2002 together with an accompanying paper 2 describing the methodology. The two papers were rejected by the BMJ and then submitted to Sexually Transmitted Infections (STI) in June 2002, which accepted both papers in October 2002. Over the same period, the investigators from Portsmouth prepared their own paper, 3 which they discussed with the DH, who agreed that it could be submitted but advised that it should not be published before the other papers. The paper from Portsmouth was submitted to STI in March 2002. However, on receiving the paper describing the national findings (in June 2002), the editor of STI (Dr Shahmanesh) considered that the paper from Portsmouth overlapped too much with the national results paper to be published separately in his journal and therefore asked the Portsmouth authors to withdraw their paper from STI, which they did in July 2002. Subsequently, the Portsmouth authors submitted their paper (unchanged) to the Journal of Family Planning and Reproductive Health Care (JFPRHC) together with copies of the national results paper that was under consideration at STI. The editor of JFPRHC agreed with the Portsmouth authors that their paper, although overlapping to some extent with the other paper, was sufficiently different to warrant publication and therefore accepted it in October 2002. Unfortunately, although the authors had been open with the editor of JFPRHC and had supplied a copy of the related paper with their submission, because they did not know the bibliographical details of the STI papers they did not reference them in the JFPRHC paper but cited a DH website, which, at the time of publication, gave details of the study. However, the DH website cited in the JFPRHC paper no longer includes information about the study, so later readers could not determine the relationship between the papers.
The Portsmouth authors also kept the trial sponsor (the DH) fully informed of their publication plans, and the DH approved the publication of the Portsmouth data on the understanding that these would be published after the national findings. The contact at the DH mistakenly believed that the papers describing the national study would appear in STI in December 2002, and this date was not checked by the Portsmouth authors (who were authors on the other publication and therefore could have obtained this information from STI) or by the editor of JFPRHC. 
